111 related articles for article (PubMed ID: 30892313)
1. Treatment of cervix carcinoma FIGO IIIb with Photofrin II as a radiosensitizer: a case report.
Schaffer P; Batash R; Ertl-Wagner B; Hofstetter A; Asna N; Schaffer M
Photochem Photobiol Sci; 2019 May; 18(5):1275-1279. PubMed ID: 30892313
[TBL] [Abstract][Full Text] [Related]
2. Treatment of astrocytoma grade III with Photofrin II as a radiosensitizer. A case report.
Schaffer M; Hofstetter A; Ertl-Wagner B; Batash R; Pöschl J; Schaffer PM
Strahlenther Onkol; 2013 Nov; 189(11):972-6. PubMed ID: 24158603
[TBL] [Abstract][Full Text] [Related]
3. Mature results of a pilot study of pelvic radiotherapy with concurrent continuous infusion intra-arterial 5-FU for stage IIIB-IVA squamous cell carcinoma of the cervix.
Chaney AW; Eifel PJ; Logsdon MD; Morris M; Wharton JT
Int J Radiat Oncol Biol Phys; 1999 Aug; 45(1):113-8. PubMed ID: 10477014
[TBL] [Abstract][Full Text] [Related]
4. Irradiation with or without misonidazole for patients with stages IIIB and IVA carcinoma of the cervix: final results of RTOG 80-05. Radiation Therapy Oncology Group.
Grigsby PW; Winter K; Wasserman TH; Marcial V; Rotman M; Cooper J; Keys H; Asbell SO; Phillips TL
Int J Radiat Oncol Biol Phys; 1999 Jun; 44(3):513-7. PubMed ID: 10348279
[TBL] [Abstract][Full Text] [Related]
5. Twice-daily fractionation of external irradiation with brachytherapy and chemotherapy in carcinoma of the cervix with positive para-aortic lymph nodes: Phase II study of the Radiation Therapy Oncology Group 92-10.
Grigsby PW; Lu JD; Mutch DG; Kim RY; Eifel PJ
Int J Radiat Oncol Biol Phys; 1998 Jul; 41(4):817-22. PubMed ID: 9652843
[TBL] [Abstract][Full Text] [Related]
6. Long-term follow-up of RTOG 92-10: cervical cancer with positive para-aortic lymph nodes.
Grigsby PW; Heydon K; Mutch DG; Kim RY; Eifel P
Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):982-7. PubMed ID: 11704321
[TBL] [Abstract][Full Text] [Related]
7. Two fractions of high-dose-rate brachytherapy in the management of cervix cancer: clinical experience with and without chemotherapy.
Sood BM; Gorla G; Gupta S; Garg M; Deore S; Runowicz CD; Fields AL; Goldberg GL; Anderson PS; Vikram B
Int J Radiat Oncol Biol Phys; 2002 Jul; 53(3):702-6. PubMed ID: 12062615
[TBL] [Abstract][Full Text] [Related]
8. Application of Photofrin II as a specific radiosensitising agent in patients with bladder cancer--a report of two cases.
Schaffer M; Schaffer PM; Vogesser M; Ertl-Wagner B; Rauch J; Oberneder R; Jori G; Hofstetter A; Dühmke E
Photochem Photobiol Sci; 2002 Sep; 1(9):686-9. PubMed ID: 12665306
[TBL] [Abstract][Full Text] [Related]
9. The Application of Photofrin II as a sensitizing agent for ionizing radiation--a new approach in tumor therapy?
Schaffer M; Ertl-Wagner B; Schaffer PM; Kulka U; Jori G; Dühmke E; Hofstetter A
Curr Med Chem; 2005; 12(10):1209-15. PubMed ID: 15892632
[TBL] [Abstract][Full Text] [Related]
10. Laparoscopic surgical staging in cervical cancer--preliminary experience among Chinese.
Chu KK; Chang SD; Chen FP; Soong YK
Gynecol Oncol; 1997 Jan; 64(1):49-53. PubMed ID: 8995546
[TBL] [Abstract][Full Text] [Related]
11. [Locally advanced carcinoma of the cervix uteri (stage IIB-IIIB TNM-UICC): radiotherapy combined with simultaneous daily low-dose platinum. Phase II study].
Micheletti E; La Face B; Bianchi E; Cagna E; Sartori E
Radiol Med; 1996 May; 91(5):628-34. PubMed ID: 8693131
[TBL] [Abstract][Full Text] [Related]
12. Photofrin as a specific radiosensitizing agent for tumors: studies in comparison to other porphyrins, in an experimental in vivo model.
Schaffer M; Schaffer PM; Corti L; Gardiman M; Sotti G; Hofstetter A; Jori G; Dühmke E
J Photochem Photobiol B; 2002 Apr; 66(3):157-64. PubMed ID: 11960724
[TBL] [Abstract][Full Text] [Related]
13. Figo IIIB squamous cell carcinoma of the cervix: an analysis of prognostic factors emphasizing the balance between external beam and intracavitary radiation therapy.
Logsdon MD; Eifel PJ
Int J Radiat Oncol Biol Phys; 1999 Mar; 43(4):763-75. PubMed ID: 10098431
[TBL] [Abstract][Full Text] [Related]
14. Phase I clinical trial of weekly paclitaxel, weekly carboplatin, and concurrent radiotherapy for primary cervical cancer.
Rao GG; Rogers P; Drake RD; Nguyen P; Coleman RL
Gynecol Oncol; 2005 Jan; 96(1):168-72. PubMed ID: 15589596
[TBL] [Abstract][Full Text] [Related]
15. Mature results of a phase II trial of concomitant cisplatin/pelvic radiotherapy for locally advanced squamous cell carcinoma of the cervix.
Fields AL; Anderson PS; Goldberg GL; Wadler S; Beitler J; Sood B; Runowicz CD
Gynecol Oncol; 1996 Jun; 61(3):416-22. PubMed ID: 8641625
[TBL] [Abstract][Full Text] [Related]
16. Hyperfractionated radiotherapy with concurrent chemotherapy for para-aortic lymph node recurrence in carcinoma of the cervix.
Kim JS; Kim JS; Kim SY; Kim Ki; Cho MJ
Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1247-53. PubMed ID: 12654434
[TBL] [Abstract][Full Text] [Related]
17. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
Morris M; Eifel PJ; Lu J; Grigsby PW; Levenback C; Stevens RE; Rotman M; Gershenson DM; Mutch DG
N Engl J Med; 1999 Apr; 340(15):1137-43. PubMed ID: 10202164
[TBL] [Abstract][Full Text] [Related]
18. Uterus necrosis after radiochemotherapy in two patients with advanced cervical cancer.
Marnitz S; Köhler C; Füller J; Hinkelbein W; Schneider A
Strahlenther Onkol; 2006 Jan; 182(1):45-51. PubMed ID: 16404520
[TBL] [Abstract][Full Text] [Related]
19. High complete response rate of concomitant chemoradiotherapy for locally advanced squamous cell carcinoma of the uterine cervix.
Lin JC; Ho ES; Jan JS; Yang CH; Liu FS
Gynecol Oncol; 1996 Apr; 61(1):101-8. PubMed ID: 8626094
[TBL] [Abstract][Full Text] [Related]
20. Impact of MRI in the management and staging of cancer of the uterine cervix.
Stenstedt K; Hellström AC; Fridsten S; Blomqvist L
Acta Oncol; 2011 Apr; 50(3):420-6. PubMed ID: 21166605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
